Bespoke research support on the companion diagnostics market

“We provide in-depth insight across leading healthcare diagnostic tests including in-vitro diagnostics (IVD) and molecular diagnostics for disease detection, key emerging trends, market sizing and forecasting”

The pandemic has had a positive impact on the companion diagnostics market due to the rising number of diagnostic procedures including polymerase chain reaction (PCR), next-generation sequencing (NGS), in situ hybridisation, immunohistochemistry, genome sequencing and molecular diagnostics

The growing significance of personalised medicine, the rising incidence of cancer and COVID-19 PCR testing, technological advancements and recent product launches will likely drive further growth in the global companion diagnostics market.

Most leading pharmaceutical and biotechnology companies including Thermo Fischer Scientific Inc., Illumina Inc., Bayer AG, F. Hoffmann-La Roche AG, Siemens Healthineers AG and Danaher Corporation Ltd are using companion diagnostics (CDx) kits and reagents to detect, for example, cancer, neurological disorders, heart disease, infectious diseases, respiratory and gastroenterological diseases and genetic disorders.

Our oncology subject-matter experts can provide assistance with research and insight in the field of oncology therapy including competitive intelligence, pipeline analysis and benchmarking, and market entry and due diligence.


Our offering

Oncology diagnostics research

Tap to flip

We help you manage the bulk of the research, freeing up your time to focus on more important areas

  • Recent trends and technologies

  • Competitive intelligence

  • Daily/weekly alerts tracking assets/competitors

  • KOL identification and primary research

  • Competitor profiling and benchmarking

  • Market assessment and sizing

  • Commercial and scientific conference coverage

  • Latest diagnostics products (kits, reagents, assays, services and software) launches

  • Updating internal databases

  • Literature searches and newsletters

Strategy research and due diligence projects

Tap to flip

Our extensive research capabilities can help you efficiently manage increased demand

  • Opportunity assessment and market attractiveness

  • Product launch strategies

  • Licensing and acquisition

  • Market entry and due diligence

  • Pricing and reimbursement strategies

  • Technology or partner scouting

Support with regulatory policies in healthcare

Tap to flip

We have been keeping abreast of changes in regulation and can help you create a master report along with daily/weekly alerts tracking recent changes

  • Regulatory approval in different countries

  • Regulatory barriers and strategies to overcome them

  • Pricing and reimbursement policies

  • Patient access programmes

  • Macroeconomic policies of different countries

Thank you for sharing your details

Share this on